Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Arzneimittel-Forschung|January 1, 1983
[Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid]G Grünzig, P W Lücker, J SchnitkerJournal of Computer-Aided Molecular Design|January 1, 1997
Objective models for steroid binding sites of human globulinsJ Schnitker, R Gopalaswamy, G M CrippenArzneimittel-Forschung|January 1, 1976
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamideJ Schnitker, N Brock, H Burkert, et al.Contraception|February 1, 1991
Clinical experience with a modern low-dose oral contraceptive in almost 100,000 usersK Brill, T Norpoth, J Schnitker, et al.Clinical and Experimental Rheumatology|March 17, 2006
Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugsG Klein, W Kullich, J Schnitker, et al.Arzneimittel-Forschung|January 1, 1983
[A test model for cerebrally-active drugs as demonstrated by the example of the new substance aniracetam]P Foltyn, P W Lücker, J Schnitker, et al.Allergy|May 19, 2004
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparationsF Ruëff, H Wolf, J Schnitker, et al.The Journal of Allergy and Clinical Immunology|June 16, 2000
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injectionsR Brehler, H Wolf, B Kütting, et al.Arzneimittel-Forschung|January 1, 1982
[Pharmacokinetic studies on plasma elimination half-life of oxipurinol (author's transl)]H J Lach, B Bader, J Schnitker, et al.Annals of the Rheumatic Diseases|August 9, 2011
Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?A Braun, E Saracbasi, J Grifka, et al.Pageof 5